Real Word Evidence With 1L Polyethylene Glycol (PEG)+ Ascorbic Acid in Iberia
NCT05174845
Colon Cancer, Colon Cleansing
Guimarães, Portugal
View Trial DetailsNCT Number: NCT00906217
This study aims to further define the appropriate population for Pico-Salax, a purgative used prior to colonoscopy. Patients over the age of 70 years with normal renal function scheduled for colonoscopy will receive Pico-Salax and have pre and post preparation bloodwork and electrocardiograms (ECGs).
Looking for future studies?
Notify Me70 year and older
All sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 2 months
Queen's University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05174845
Colon Cancer, Colon Cleansing
Guimarães, Portugal
View Trial DetailsNCT02273141
Colon Cleansing, Colonic Diseases
Berlin, Germany
View Trial DetailsNCT02273167
Colon Cleansing, Colonic Diseases
Bruges, Belgium
View Trial DetailsNCT02254486
Colon Cancer, Colon Cleansing
Anaheim, California, United States
View Trial Details